Aclaris Therapeutics updates corporate presentation; no material new data disclosed

Aclaris Therapeutics, Inc.

Company posted an updated investor presentation on January 13, 2025.
Presentation content not fully available in this filing for review.
Routine update; no earnings, pipeline, or financial guidance changes announced.
Presentation available on Aclaris website.

item 7.01 item 9.01

Aclaris Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-25-000148

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.